Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (91-100 of 487) with videos related to

Pageof 49
Sort By:
BMJ Case Reports|April 25, 2019
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biologyKalevi Kairemo, Wei-Lien Wang, Vivek Subbiah
JAMA Oncology|May 26, 2018
Hypopigmented Skin Lesions After ImmunotherapyEcaterina Ileana Dumbrava, Doina Ivan, Vivek Subbiah
Cancer|March 22, 2023
Top advances of the year: Precision oncologyAakash Desai, Neha K Reddy, Vivek Subbiah
Cancer Discovery|April 4, 2024
A Vision for Democratizing Next-Generation Oncology Clinical TrialsVivek Subbiah, Denis Horgan, Ishwaria M Subbiah
Advances in Experimental Medicine and Biology|June 14, 2014
Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223Peter M Anderson, Vivek Subbiah, Eric Rohren
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Evolving Landscape of Antibody Drug Conjugates in LymphomaRishab Prakash, Vivek Subbiah, Swaminathan P Iyer
International Journal of Cancer|December 16, 2017
Precision oncology: East meets WestVivek Subbiah, Jordi Rodon, Timothy A Yap
Expert Opinion on Investigational Drugs|September 23, 2011
Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?Vivek Subbiah, Laura S Angelo, Razelle Kurzrock
JCO Oncology Practice|March 2, 2026
From Information Overload to Patient-Centered Oncology Care Through ApomediationZouina Sarfraz, Vivek Subbiah, Manmeet S Ahluwalia
Cancer|November 7, 2023
Revolutionizing cancer drug development: Harnessing the potential of basket trialsVivek Subbiah, Howard A Burris, Razelle Kurzrock
Pageof 49

Showing results (91-100 of 487) with videos related to

Sort By:
Pageof 49
BMJ Case Reports|April 25, 2019
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biologyKalevi Kairemo, Wei-Lien Wang, Vivek Subbiah
JAMA Oncology|May 26, 2018
Hypopigmented Skin Lesions After ImmunotherapyEcaterina Ileana Dumbrava, Doina Ivan, Vivek Subbiah
Cancer|March 22, 2023
Top advances of the year: Precision oncologyAakash Desai, Neha K Reddy, Vivek Subbiah
Cancer Discovery|April 4, 2024
A Vision for Democratizing Next-Generation Oncology Clinical TrialsVivek Subbiah, Denis Horgan, Ishwaria M Subbiah
Advances in Experimental Medicine and Biology|June 14, 2014
Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223Peter M Anderson, Vivek Subbiah, Eric Rohren
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Evolving Landscape of Antibody Drug Conjugates in LymphomaRishab Prakash, Vivek Subbiah, Swaminathan P Iyer
International Journal of Cancer|December 16, 2017
Precision oncology: East meets WestVivek Subbiah, Jordi Rodon, Timothy A Yap
Expert Opinion on Investigational Drugs|September 23, 2011
Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?Vivek Subbiah, Laura S Angelo, Razelle Kurzrock
JCO Oncology Practice|March 2, 2026
From Information Overload to Patient-Centered Oncology Care Through ApomediationZouina Sarfraz, Vivek Subbiah, Manmeet S Ahluwalia
Cancer|November 7, 2023
Revolutionizing cancer drug development: Harnessing the potential of basket trialsVivek Subbiah, Howard A Burris, Razelle Kurzrock
Pageof 49